Matthew A. Nehs

Also affiliated with Harvard University, Massachusetts General Hospital, Mass General Brigham

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E -Driven Papillary Thyroid Cancer Patients”.

Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E -Driven Papillary Thyroid Cancer Patients

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0874

N/A

0DataRank · unranked

59 citations

Sara Ahmadi, Ellen Marqusee, Hannah Johnson, Matthew A. Nehs, Nancy L. Cho +7 more

Glycolytic inhibition with 3-bromopyruvate suppresses tumor growth and improves survival in a murine model of anaplastic thyroid cancer

Surgery(2021)10.1016/j.surg.2021.05.055

N/A

0DataRank · unranked

20 citations

Abha Aggarwal, Jessica A. Marshall, Justine A. Barletta, Marie Foley Kijewski, Jochen H. Lorch +2 more

Limited disease progression in endocrine surgery patients with treatment delays due to COVID-19

Surgery(2022)10.1016/j.surg.2022.06.043

N/A

0DataRank · unranked

9 citations

Catherine DiGennaro, Toni Beninato, Rajshri M. Gartland, Natalia Chaves, Jordan M. Broekhuis +31 more

Additional Oncogenic Alterations in RAS -Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0278

N/A

0DataRank · unranked

27 citations

Sara Ahmadi, Θεοδώρα Παππά, Ellen Marqusee, Kristine Wong, Matthew A. Nehs +8 more

Data from Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E-Driven Papillary Thyroid Cancer Patients

(2023)10.1158/1078-0432.c.6530706

N/A

0DataRank · unranked

0 citations

Sara Ahmadi, Ellen Marqusee, Hannah Johnson, Matthew A. Nehs, Nancy L. Cho +7 more

Data from Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E-Driven Papillary Thyroid Cancer Patients

(2023)10.1158/1078-0432.c.6530706.v1

N/A

0DataRank · unranked

0 citations

Sara Ahmadi, Ellen Marqusee, Hannah Johnson, Matthew A. Nehs, Nancy L. Cho +7 more